PDB Short entry for 1MQ1 HEADER METAL BINDING PROTEIN 13-SEP-02 1MQ1 TITLE CA2+-S100B-TRTK-12 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-100 PROTEIN, BETA CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: F-ACTIN CAPPING PROTEIN ALPHA-1 SUBUNIT; COMPND 7 CHAIN: C, D; COMPND 8 FRAGMENT: TRTK-12 PEPTIDE, RESIDUES 265-276; COMPND 9 SYNONYM: CAPZ ALPHA-1, TRTK-12 PEPTIDE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: S100BETA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: N99; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSS2; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THE PEPTIDE IS CHEMICALLY SYNTHESIZED. KEYWDS PROTEIN-PEPTIDE COMPLEX, EF-HAND, METAL BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 17 AUTHOR K.A.MCCLINTOCK,G.S.SHAW REVDAT 4 23-FEB-22 1MQ1 1 REMARK REVDAT 3 24-FEB-09 1MQ1 1 VERSN REVDAT 2 31-MAY-05 1MQ1 1 JRNL REVDAT 1 25-DEC-02 1MQ1 0 JRNL AUTH K.A.MCCLINTOCK,G.S.SHAW JRNL TITL A NOVEL S100 TARGET CONFORMATION IS REVEALED BY THE SOLUTION JRNL TITL 2 STRUCTURE OF THE CA2+-S100B-TRTK-12 COMPLEX. JRNL REF J.BIOL.CHEM. V. 278 6251 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12480931 JRNL DOI 10.1074/JBC.M210622200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MQ1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1000017086. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 7.05 REMARK 210 IONIC STRENGTH : 35 MM KCL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : U-13C, U-15N S100B (1.0 MM) REMARK 210 UNLABELLED TRTK-12 (1.2 MM) 3 MM REMARK 210 CACL2; U-2H, U-15N S100B (0.35 REMARK 210 MM) UNLABELLED TRTK-12 (0.80 MM) REMARK 210 1 MM CACL2; U-13C, U-15N S100B REMARK 210 (1.0 MM) 13C-ACETYL, 13C-ILE REMARK 210 TRTK-12 (1.2 MM) 3 MM CACL2; U- REMARK 210 13C/U-12C S100B HETERODIMER REMARK 210 (1.0MM) UNLABELLED TRTK-12 (1.2 REMARK 210 MM) 3 MM CACL2 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 3D_13C/15N REMARK 210 -SEPARATED_NOESY; 3D_15N- REMARK 210 SEPARATED_NOESY; 13C F1-EDITED, REMARK 210 F3-FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY; INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 6.1B/ 6.1C, NMRPIPE 2.1, REMARK 210 PIPP 4.3.3, CNS 1.1 REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 80 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 17 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 16 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU B 27 H CYS B 68 1.52 REMARK 500 O LEU A 27 H CYS A 68 1.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 24 -170.44 62.67 REMARK 500 1 LEU A 40 77.47 -109.13 REMARK 500 1 LEU A 44 -71.70 -89.23 REMARK 500 1 GLU A 45 -64.20 68.34 REMARK 500 1 LYS A 48 -87.22 -93.85 REMARK 500 1 ASP A 61 102.09 -44.95 REMARK 500 1 ASP A 63 -94.34 -50.45 REMARK 500 1 ASP A 69 -153.84 -93.88 REMARK 500 1 PHE A 76 -70.73 -66.97 REMARK 500 1 LYS B 24 -170.41 62.55 REMARK 500 1 LEU B 40 77.57 -109.15 REMARK 500 1 LEU B 44 -71.77 -89.27 REMARK 500 1 GLU B 45 -64.16 68.43 REMARK 500 1 LYS B 48 -87.10 -93.87 REMARK 500 1 ASP B 61 102.11 -44.94 REMARK 500 1 ASP B 63 -94.45 -50.37 REMARK 500 1 ASP B 69 -153.85 -93.80 REMARK 500 1 PHE B 76 -70.76 -66.92 REMARK 500 1 ARG C 2 -71.41 -58.61 REMARK 500 1 ILE C 5 -14.11 57.15 REMARK 500 1 ASP C 6 -10.11 69.09 REMARK 500 1 TRP C 7 -70.35 -50.89 REMARK 500 1 ASN C 8 -93.43 150.36 REMARK 500 1 ARG D 2 -71.48 -58.52 REMARK 500 1 ILE D 5 -14.27 57.22 REMARK 500 1 ASP D 6 -10.10 69.15 REMARK 500 1 TRP D 7 -70.28 -50.90 REMARK 500 1 ASN D 8 -93.57 150.38 REMARK 500 2 GLU A 21 171.60 -57.44 REMARK 500 2 HIS A 25 -30.61 -179.88 REMARK 500 2 GLU A 39 50.01 -147.64 REMARK 500 2 LEU A 40 87.45 -154.26 REMARK 500 2 PHE A 43 -170.19 -173.97 REMARK 500 2 GLU A 45 -60.73 -96.12 REMARK 500 2 ASP A 61 99.28 -38.83 REMARK 500 2 ASP A 63 30.01 80.18 REMARK 500 2 ASP A 65 37.42 -173.24 REMARK 500 2 ASP A 69 -167.78 -101.17 REMARK 500 2 PHE A 76 -74.90 -62.10 REMARK 500 2 GLU A 89 171.64 60.46 REMARK 500 2 GLU B 21 171.57 -57.59 REMARK 500 2 HIS B 25 -30.62 -179.92 REMARK 500 2 GLU B 39 50.04 -147.75 REMARK 500 2 LEU B 40 87.40 -154.24 REMARK 500 2 PHE B 43 -170.21 -174.03 REMARK 500 2 GLU B 45 -60.73 -96.14 REMARK 500 2 ASP B 61 99.21 -38.73 REMARK 500 2 ASP B 63 30.17 80.07 REMARK 500 2 ASP B 65 37.36 -173.18 REMARK 500 2 ASP B 69 -167.75 -101.10 REMARK 500 REMARK 500 THIS ENTRY HAS 531 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UWO RELATED DB: PDB REMARK 900 HUMAN CALCIUM-BOUND S100B DBREF 1MQ1 A 1 91 UNP P04271 S100B_HUMAN 1 91 DBREF 1MQ1 B 1 91 UNP P04271 S100B_HUMAN 1 91 DBREF 1MQ1 C 1 12 UNP P52907 CAZA1_HUMAN 265 276 DBREF 1MQ1 D 1 12 UNP P52907 CAZA1_HUMAN 265 276 SEQRES 1 A 91 SER GLU LEU GLU LYS ALA MET VAL ALA LEU ILE ASP VAL SEQRES 2 A 91 PHE HIS GLN TYR SER GLY ARG GLU GLY ASP LYS HIS LYS SEQRES 3 A 91 LEU LYS LYS SER GLU LEU LYS GLU LEU ILE ASN ASN GLU SEQRES 4 A 91 LEU SER HIS PHE LEU GLU GLU ILE LYS GLU GLN GLU VAL SEQRES 5 A 91 VAL ASP LYS VAL MET GLU THR LEU ASP ASN ASP GLY ASP SEQRES 6 A 91 GLY GLU CYS ASP PHE GLN GLU PHE MET ALA PHE VAL ALA SEQRES 7 A 91 MET VAL THR THR ALA CYS HIS GLU PHE PHE GLU HIS GLU SEQRES 1 B 91 SER GLU LEU GLU LYS ALA MET VAL ALA LEU ILE ASP VAL SEQRES 2 B 91 PHE HIS GLN TYR SER GLY ARG GLU GLY ASP LYS HIS LYS SEQRES 3 B 91 LEU LYS LYS SER GLU LEU LYS GLU LEU ILE ASN ASN GLU SEQRES 4 B 91 LEU SER HIS PHE LEU GLU GLU ILE LYS GLU GLN GLU VAL SEQRES 5 B 91 VAL ASP LYS VAL MET GLU THR LEU ASP ASN ASP GLY ASP SEQRES 6 B 91 GLY GLU CYS ASP PHE GLN GLU PHE MET ALA PHE VAL ALA SEQRES 7 B 91 MET VAL THR THR ALA CYS HIS GLU PHE PHE GLU HIS GLU SEQRES 1 C 12 THR ARG THR LYS ILE ASP TRP ASN LYS ILE LEU SER SEQRES 1 D 12 THR ARG THR LYS ILE ASP TRP ASN LYS ILE LEU SER HELIX 1 1 SER A 1 SER A 18 1 18 HELIX 2 2 LYS A 28 LEU A 40 1 13 HELIX 3 3 GLU A 49 ASP A 61 1 13 HELIX 4 4 ASP A 69 PHE A 88 1 20 HELIX 5 5 SER B 1 SER B 18 1 18 HELIX 6 6 LYS B 28 LEU B 40 1 13 HELIX 7 7 GLU B 49 ASP B 61 1 13 HELIX 8 8 ASP B 69 PHE B 88 1 20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000